查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1956801

動物驅蟲藥市場分析及預測（至2035年）：類型、產品、應用、最終用戶、劑型、技術、組件、階段、模式與安裝類型

Animal Parasiticides Market Analysis and Forecast to 2035: Type, Product, Application, End User, Form, Technology, Component, Stage, Mode, Installation Type
出版日期: | 出版商: Global Insight Services | 英文 392 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

動物驅蟲市場預計將從2024年的101億美元成長到2034年的165億美元，複合年成長率約為5%。動物驅蟲市場涵蓋用於預防和消除動物寄生蟲感染的產品，包括體內寄生蟲殺滅劑、體外寄生蟲殺滅劑和Endectocides用途殺蟲劑。這些產品對於維持牲畜和伴侶動物的健康和生產力至關重要。推動市場成長的因素包括動物健康意識的提高、畜牧業生產的成長以及獸醫的進步。創新重點在於提高頻譜療效、簡化給藥流程和增強安全性，以滿足日益成長的有效寄生蟲控制解決方案的需求。

受動物健康意識增強和寵物主人數量不斷成長的推動，動物驅蟲市場正經歷強勁成長。其中，體內寄生蟲防治劑是成長最快的細分市場，對控制牲畜和伴侶動物體內寄生蟲至關重要。口服製劑因其給藥方便、療效顯著，在該細分市場中佔據主導地位。其次是體外寄生蟲防治劑，用於控制跳蚤和蜱蟲等體外寄生蟲。滴劑製劑在該細分市場中尤其受歡迎，因為它給藥方便，且能提供持久的保護。牲畜市場是推動市場成長的主要動力，反映了肉類和乳製品需求的成長。由於寵物人性化趨勢的日益增強，伴侶動物市場也蘊藏著巨大的成長潛力。驅蟲製劑的創新，例如複方製劑和新型活性成分，正在提高驅蟲藥的療效和安全性。越來越多的新產品獲得監管部門核准，進一步推動了市場擴張，並為業內相關人員提供了盈利的機會。

市場區隔
類型 體內殺寄生蟲劑、體外殺寄生蟲劑、Endectocides
產品 口服藥片、注射、外用/滴劑、噴霧、項圈、洗髮精和浸浴劑
目的 獸醫診所、畜牧場、家庭護理、研究機構
最終用戶 伴侶動物、牲畜和水產養殖
形式 液體、固體、半固體
科技 化學合成，生物來源成分
成分 活性成分、添加劑
階段 開發與商業化
模式 預防和治療
安裝類型 獨立式、整合式

動物驅蟲藥市場的特點是市場佔有率波動較大，這主要受競爭激烈的價格策略和不斷湧現的創新產品的影響。各公司正利用先進的配方技術和給藥方式來搶佔關鍵市場，並提高藥效和用戶便利性。策略聯盟和收購也十分頻繁，使公司能夠擴展產品系列和地理覆蓋範圍。價格競爭依然激烈，主要受原物料成本和監管合規性的影響，而成本效益是打入新興市場的關鍵。主要產業參與者不斷相互比較，以保持競爭優勢，這構成了競爭格局的特徵。法規結構，尤其是在北美和歐洲，在塑造市場動態、影響市場核准和打入市場策略發揮著至關重要的作用。此外，嚴格的環境法規和消費者需求正在推動市場轉向環保和永續的驅蟲產品。這種法規環境與技術進步相結合，既給市場參與者帶來了挑戰，也帶來了機會。

主要趨勢和促進因素：

由於人們對動物健康和福利的意識不斷增強，動物驅蟲市場正在成長。這一趨勢主要受對高品質動物性食品需求不斷成長的推動。消費者健康意識的提高，使得他們越來越傾向於選擇無病蟲害的肉類和乳製品。這導致驅蟲產品的使用量激增，以確保牲畜的健康和生產力。獸醫領域的科技創新也正在推動市場發展。藥物配方和給藥方式的創新提高了驅蟲產品的療效和安全性，促使獸醫和養殖戶更多地使用驅蟲產品。此外，伴侶動物數量的增加和寵物醫療保健支出的成長也促進了市場擴張。世界各國政府的監管支持也是一個關鍵促進因素。各國政府正在實施嚴格的法規來遏制寄生蟲感染，從而推動了對有效驅蟲產品的需求。此外，新興國家畜牧業的擴張也為市場參與者帶來了盈利的機會。專注於研發以推出新穎環保產品的公司，更有可能充分利用這些機會。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 體內殺寄生蟲劑
    • 體外寄生蟲殺滅劑
    • 體內和體外殺寄生蟲劑
  • 市場規模及預測：依產品分類
    • 口服錠劑
    • 注射
    • 傾倒式，精準到位
    • 噴
    • 衣領
    • 洗髮精
    • 沾醬
  • 市場規模及預測：依應用領域分類
    • 獸醫診所
    • 畜牧場
    • 居家照護
    • 研究所
  • 市場規模及預測：依最終用戶分類
    • 伴侶動物
    • 家畜
    • 水產養殖
  • 市場規模及預測：依類型
    • 液體
    • 固體的
    • 半固態
  • 市場規模及預測：依技術分類
    • 化學合成
    • 生物來源製品
  • 市場規模及預測：依組件分類
    • 活性成分
    • 添加劑
  • 市場規模及預測：依階段分類
    • 發展
    • 商業化
  • 市場規模及預測：按模式
    • 預防
    • 治療
  • 市場規模及預測：依安裝類型分類
    • 獨奏
    • 一體化

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Vetoquinol
  • Virbac
  • Phibro Animal Health
  • Dechra Pharmaceuticals
  • Neogen Corporation
  • Bimeda
  • Ceva Sante Animale
  • Norbrook Laboratories
  • Huvepharma
  • Elanco Animal Health
  • Eco Animal Health
  • Sequent Scientific
  • Karyopharm Therapeutics
  • Zydus Animal Health
  • Biogenesis Bago
  • Intas Pharmaceuticals
  • KRKA
  • Bayer Animal Health
  • Orion Corporation
  • Ashish Life Science

第9章：關於我們

簡介目錄
Product Code: GIS20674

Animal Parasiticides Market is anticipated to expand from $10.1 billion in 2024 to $16.5 billion by 2034, growing at a CAGR of approximately 5%. The Animal Parasiticides Market encompasses products designed to prevent and eliminate parasitic infections in animals, including endoparasiticides, ectoparasiticides, and endectocides. These products are essential for maintaining animal health and productivity across livestock and companion animals. The market is driven by rising awareness of animal health, increasing livestock production, and advancements in veterinary pharmaceuticals. Innovations focus on broad-spectrum efficacy, ease of administration, and safety, addressing the growing demand for effective parasite management solutions.

The Animal Parasiticides Market is experiencing robust growth, driven by increasing awareness of animal health and rising pet ownership. The top-performing segment is the endoparasiticides, essential for controlling internal parasites in livestock and companion animals. Within this segment, oral formulations are leading due to their ease of administration and effectiveness. The second highest-performing segment is the ectoparasiticides, crucial for managing external parasites such as fleas and ticks. Spot-on formulations are particularly popular in this sub-segment, offering convenient application and long-lasting protection. The livestock animal category dominates, reflecting the growing demand for meat and dairy products. Companion animals also show significant growth potential, driven by the rising trend of pet humanization. Innovations in parasiticide formulations, such as combination products and novel active ingredients, are enhancing efficacy and safety. Increasing regulatory approvals for new products further support market expansion, providing lucrative opportunities for industry players.

Market Segmentation
TypeEndoparasiticides, Ectoparasiticides, Endectocides
ProductOral Tablets, Injectables, Pour-on and Spot-on, Sprays, Collars, Shampoos, Dips
ApplicationVeterinary Clinics, Animal Farms, Home Care, Research Institutes
End UserCompanion Animals, Livestock, Aquaculture
FormLiquid, Solid, Semi-Solid
TechnologyChemical Synthesis, Biological Derivatives
ComponentActive Ingredients, Excipients
StageDevelopment, Commercialization
ModePreventive, Curative
Installation TypeStandalone, Integrated

The Animal Parasiticides Market is characterized by a dynamic distribution of market share, driven by a blend of competitive pricing strategies and a steady stream of innovative product launches. Companies are leveraging advanced formulations and delivery methods to enhance efficacy and user convenience, thereby capturing significant market segments. Strategic alliances and acquisitions are prevalent, as firms seek to expand their portfolios and geographic reach. Pricing remains competitive, influenced by raw material costs and regulatory compliance, with a focus on cost-effectiveness to penetrate emerging markets. The competitive landscape is marked by the presence of key industry players who are consistently benchmarking against each other to maintain a competitive edge. Regulatory frameworks, particularly in North America and Europe, play a pivotal role in shaping market dynamics, influencing product approvals and market entry strategies. The market is also witnessing a shift towards eco-friendly and sustainable parasiticides, driven by stringent environmental regulations and consumer demand. This regulatory environment, coupled with technological advancements, presents both challenges and opportunities for market players.

Geographical Overview:

The animal parasiticides market is witnessing robust growth across various regions, each with unique dynamics. North America remains a dominant force, driven by advanced veterinary healthcare infrastructure and heightened awareness of animal health. The region's strong focus on livestock health and companion animal care fuels demand for parasiticides. Europe follows closely, supported by stringent regulations and high adoption rates of veterinary solutions. In Asia Pacific, rapid urbanization and increasing pet ownership are propelling market expansion. Countries like China and India are emerging as lucrative markets due to rising disposable incomes and growing awareness of animal welfare. Latin America and the Middle East & Africa are also gaining traction. In Latin America, the agricultural sector's expansion and livestock industry are key growth drivers. Meanwhile, the Middle East & Africa are recognizing the importance of animal health in improving food security and economic stability, thereby creating new growth pockets in the market.

Global tariffs and geopolitical tensions are significantly influencing the Animal Parasiticides Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are strategically diversifying their import sources to mitigate tariff impacts, while China is bolstering domestic production capabilities to reduce reliance on imports. Taiwan, with its advanced biotech sector, is focusing on innovation to maintain competitiveness amidst trade uncertainties. The parent market is experiencing steady growth globally, driven by increased livestock farming and pet ownership. By 2035, the market is expected to evolve with a greater emphasis on sustainable and locally produced parasiticides. Additionally, Middle East conflicts are affecting global supply chains and energy prices, indirectly impacting production costs and logistics in the animal health sector.

Key Trends and Drivers:

The Animal Parasiticides Market is experiencing growth due to heightened awareness of animal health and welfare. This trend is driven by the increasing demand for high-quality animal-derived food products. As consumers become more health-conscious, there is a growing preference for meat and dairy products free from diseases and parasites. This has led to a surge in the use of parasiticides to ensure the health and productivity of livestock. Technological advancements in veterinary medicine are also driving the market. Innovations in drug formulations and delivery methods have enhanced the efficacy and safety of parasiticides. This has encouraged their widespread adoption among veterinarians and farmers. Furthermore, the rise of companion animals, coupled with increased spending on pet healthcare, is contributing to market expansion. Regulatory support from governments worldwide is another significant driver. Authorities are implementing stringent regulations to control parasitic infections, thereby boosting the demand for effective parasiticides. Additionally, the expanding livestock industry in emerging economies presents lucrative opportunities for market players. Companies focusing on research and development to introduce novel and eco-friendly products are well-positioned to capitalize on these opportunities.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Application
  • 2.4 Key Market Highlights by End User
  • 2.5 Key Market Highlights by Form
  • 2.6 Key Market Highlights by Technology
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Stage
  • 2.9 Key Market Highlights by Mode
  • 2.10 Key Market Highlights by Installation Type

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Endoparasiticides
    • 4.1.2 Ectoparasiticides
    • 4.1.3 Endectocides
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Oral Tablets
    • 4.2.2 Injectables
    • 4.2.3 Pour-on and Spot-on
    • 4.2.4 Sprays
    • 4.2.5 Collars
    • 4.2.6 Shampoos
    • 4.2.7 Dips
  • 4.3 Market Size & Forecast by Application (2020-2035)
    • 4.3.1 Veterinary Clinics
    • 4.3.2 Animal Farms
    • 4.3.3 Home Care
    • 4.3.4 Research Institutes
  • 4.4 Market Size & Forecast by End User (2020-2035)
    • 4.4.1 Companion Animals
    • 4.4.2 Livestock
    • 4.4.3 Aquaculture
  • 4.5 Market Size & Forecast by Form (2020-2035)
    • 4.5.1 Liquid
    • 4.5.2 Solid
    • 4.5.3 Semi-Solid
  • 4.6 Market Size & Forecast by Technology (2020-2035)
    • 4.6.1 Chemical Synthesis
    • 4.6.2 Biological Derivatives
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Active Ingredients
    • 4.7.2 Excipients
  • 4.8 Market Size & Forecast by Stage (2020-2035)
    • 4.8.1 Development
    • 4.8.2 Commercialization
  • 4.9 Market Size & Forecast by Mode (2020-2035)
    • 4.9.1 Preventive
    • 4.9.2 Curative
  • 4.10 Market Size & Forecast by Installation Type (2020-2035)
    • 4.10.1 Standalone
    • 4.10.2 Integrated

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Application
      • 5.2.1.4 End User
      • 5.2.1.5 Form
      • 5.2.1.6 Technology
      • 5.2.1.7 Component
      • 5.2.1.8 Stage
      • 5.2.1.9 Mode
      • 5.2.1.10 Installation Type
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Application
      • 5.2.2.4 End User
      • 5.2.2.5 Form
      • 5.2.2.6 Technology
      • 5.2.2.7 Component
      • 5.2.2.8 Stage
      • 5.2.2.9 Mode
      • 5.2.2.10 Installation Type
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Application
      • 5.2.3.4 End User
      • 5.2.3.5 Form
      • 5.2.3.6 Technology
      • 5.2.3.7 Component
      • 5.2.3.8 Stage
      • 5.2.3.9 Mode
      • 5.2.3.10 Installation Type
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Application
      • 5.3.1.4 End User
      • 5.3.1.5 Form
      • 5.3.1.6 Technology
      • 5.3.1.7 Component
      • 5.3.1.8 Stage
      • 5.3.1.9 Mode
      • 5.3.1.10 Installation Type
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Application
      • 5.3.2.4 End User
      • 5.3.2.5 Form
      • 5.3.2.6 Technology
      • 5.3.2.7 Component
      • 5.3.2.8 Stage
      • 5.3.2.9 Mode
      • 5.3.2.10 Installation Type
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Application
      • 5.3.3.4 End User
      • 5.3.3.5 Form
      • 5.3.3.6 Technology
      • 5.3.3.7 Component
      • 5.3.3.8 Stage
      • 5.3.3.9 Mode
      • 5.3.3.10 Installation Type
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Application
      • 5.4.1.4 End User
      • 5.4.1.5 Form
      • 5.4.1.6 Technology
      • 5.4.1.7 Component
      • 5.4.1.8 Stage
      • 5.4.1.9 Mode
      • 5.4.1.10 Installation Type
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Application
      • 5.4.2.4 End User
      • 5.4.2.5 Form
      • 5.4.2.6 Technology
      • 5.4.2.7 Component
      • 5.4.2.8 Stage
      • 5.4.2.9 Mode
      • 5.4.2.10 Installation Type
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Application
      • 5.4.3.4 End User
      • 5.4.3.5 Form
      • 5.4.3.6 Technology
      • 5.4.3.7 Component
      • 5.4.3.8 Stage
      • 5.4.3.9 Mode
      • 5.4.3.10 Installation Type
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Application
      • 5.4.4.4 End User
      • 5.4.4.5 Form
      • 5.4.4.6 Technology
      • 5.4.4.7 Component
      • 5.4.4.8 Stage
      • 5.4.4.9 Mode
      • 5.4.4.10 Installation Type
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Application
      • 5.4.5.4 End User
      • 5.4.5.5 Form
      • 5.4.5.6 Technology
      • 5.4.5.7 Component
      • 5.4.5.8 Stage
      • 5.4.5.9 Mode
      • 5.4.5.10 Installation Type
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Application
      • 5.4.6.4 End User
      • 5.4.6.5 Form
      • 5.4.6.6 Technology
      • 5.4.6.7 Component
      • 5.4.6.8 Stage
      • 5.4.6.9 Mode
      • 5.4.6.10 Installation Type
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Application
      • 5.4.7.4 End User
      • 5.4.7.5 Form
      • 5.4.7.6 Technology
      • 5.4.7.7 Component
      • 5.4.7.8 Stage
      • 5.4.7.9 Mode
      • 5.4.7.10 Installation Type
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Application
      • 5.5.1.4 End User
      • 5.5.1.5 Form
      • 5.5.1.6 Technology
      • 5.5.1.7 Component
      • 5.5.1.8 Stage
      • 5.5.1.9 Mode
      • 5.5.1.10 Installation Type
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Application
      • 5.5.2.4 End User
      • 5.5.2.5 Form
      • 5.5.2.6 Technology
      • 5.5.2.7 Component
      • 5.5.2.8 Stage
      • 5.5.2.9 Mode
      • 5.5.2.10 Installation Type
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Application
      • 5.5.3.4 End User
      • 5.5.3.5 Form
      • 5.5.3.6 Technology
      • 5.5.3.7 Component
      • 5.5.3.8 Stage
      • 5.5.3.9 Mode
      • 5.5.3.10 Installation Type
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Application
      • 5.5.4.4 End User
      • 5.5.4.5 Form
      • 5.5.4.6 Technology
      • 5.5.4.7 Component
      • 5.5.4.8 Stage
      • 5.5.4.9 Mode
      • 5.5.4.10 Installation Type
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Application
      • 5.5.5.4 End User
      • 5.5.5.5 Form
      • 5.5.5.6 Technology
      • 5.5.5.7 Component
      • 5.5.5.8 Stage
      • 5.5.5.9 Mode
      • 5.5.5.10 Installation Type
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Application
      • 5.5.6.4 End User
      • 5.5.6.5 Form
      • 5.5.6.6 Technology
      • 5.5.6.7 Component
      • 5.5.6.8 Stage
      • 5.5.6.9 Mode
      • 5.5.6.10 Installation Type
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Application
      • 5.6.1.4 End User
      • 5.6.1.5 Form
      • 5.6.1.6 Technology
      • 5.6.1.7 Component
      • 5.6.1.8 Stage
      • 5.6.1.9 Mode
      • 5.6.1.10 Installation Type
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Application
      • 5.6.2.4 End User
      • 5.6.2.5 Form
      • 5.6.2.6 Technology
      • 5.6.2.7 Component
      • 5.6.2.8 Stage
      • 5.6.2.9 Mode
      • 5.6.2.10 Installation Type
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Application
      • 5.6.3.4 End User
      • 5.6.3.5 Form
      • 5.6.3.6 Technology
      • 5.6.3.7 Component
      • 5.6.3.8 Stage
      • 5.6.3.9 Mode
      • 5.6.3.10 Installation Type
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Application
      • 5.6.4.4 End User
      • 5.6.4.5 Form
      • 5.6.4.6 Technology
      • 5.6.4.7 Component
      • 5.6.4.8 Stage
      • 5.6.4.9 Mode
      • 5.6.4.10 Installation Type
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Application
      • 5.6.5.4 End User
      • 5.6.5.5 Form
      • 5.6.5.6 Technology
      • 5.6.5.7 Component
      • 5.6.5.8 Stage
      • 5.6.5.9 Mode
      • 5.6.5.10 Installation Type

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Vetoquinol
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Virbac
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Phibro Animal Health
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Dechra Pharmaceuticals
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Neogen Corporation
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Bimeda
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Ceva Sante Animale
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Norbrook Laboratories
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Huvepharma
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Elanco Animal Health
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Eco Animal Health
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Sequent Scientific
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Karyopharm Therapeutics
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Zydus Animal Health
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Biogenesis Bago
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Intas Pharmaceuticals
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 KRKA
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Bayer Animal Health
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Orion Corporation
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Ashish Life Science
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us